Insights On CONTRACT PHARMA MANUFACTURING

  1. Choosing The Right Sterility Strategy For Powder Injectables 8/20/2026

    Developing powder injectables requires matching sterilization to product traits. Early cross-functional planning and tight contamination controls build sterility assurance before clinical work starts.

  2. From API Synthesis To Drug Product Shelf Life 8/20/2026

    Fragmented drug development causes delays and added costs. Unifying API synthesis, fill-finish, and testing streamlines logistics, preserves product data, and accelerates regulatory timelines.

  3. Scaling A Sterile Fill-Finish Program 4x Without Adding Complexity 8/20/2026

    Scaling sterile fill-finish operations requires balancing tight clinical timelines with flexibility. Single-use formulation systems eliminate major capital costs, reduce cleaning burdens, and speed turnarounds without sacrificing product quality.

  4. Curia's Approach To Regulatory Compliance In Japan 8/20/2026

    Japan's pharmaceutical market demands J-DMF registration, Foreign Manufacturer Accreditation, and GMP compliance. Learn how experienced CDMO support simplifies PMDA submissions and accelerates your market entry.

  5. Quality With Purpose: From Manufacturing Excellence To Patient Impact 8/19/2026

    When quality and purpose align, pharmaceutical teams can overcome challenges, accelerate innovation, and bring safe, effective therapies to patients worldwide.

  6. New Promises, New Pressures, No Problem - Service Care Packages 8/19/2026

    Tighter production schedules leave little room for equipment disruption. Get support that can strengthen maintenance strategies, reduce operational risk, and help internal teams sustain performance.

  7. Lyophilization Process Development For Antibody Drug Conjugates 8/18/2026

    See how scientific process development and QbD principles improve freeze-drying performance, strengthen product stability, and support biologics scale-up.

  8. Lonza Capabilities Update August 2026: Cell Line Development 8/18/2026

    Omeco Barrett, Principal Scientist, Global Process Development, highlights Lonza’s latest development in cell line expression technology and cell line development (CLD).

  9. Why Upstream-Downstream Alignment Determines Success In Complex Biologics 8/18/2026

    Aligning early upstream choices, downstream purification, and analytical testing prevents scale-up delays, reduces process variability, and protects timelines for complex biologics.

  10. Maximizing Drug Formulation For First-In-Human Trials 8/17/2026

    Discover how integrated formulation, manufacturing, and clinical strategies can accelerate early drug development, reduce timelines, and optimize drug products for clinical success.